Cefminox

DB09062

small molecule experimental

Deskripsi

Cefminox (INN) is a second generation cephalosporin antibiotic. It is approved for use in Japan.

Struktur Molekul 2D

Berat 519.57
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

796 Data
Probenecid The serum concentration of Cefminox can be increased when it is combined with Probenecid.
Foscarnet The risk or severity of nephrotoxicity can be increased when Cefminox is combined with Foscarnet.
Mannitol The risk or severity of nephrotoxicity can be increased when Mannitol is combined with Cefminox.
Tenofovir disoproxil Cefminox may increase the nephrotoxic activities of Tenofovir disoproxil.
Tenofovir alafenamide Cefminox may increase the nephrotoxic activities of Tenofovir alafenamide.
Tenofovir Cefminox may increase the nephrotoxic activities of Tenofovir.
Picosulfuric acid The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Cefminox.
Cyclosporine The risk or severity of nephrotoxicity can be increased when Cyclosporine is combined with Cefminox.
Icosapent The risk or severity of nephrotoxicity can be increased when Icosapent is combined with Cefminox.
Cefotiam The risk or severity of nephrotoxicity can be increased when Cefotiam is combined with Cefminox.
Mesalazine The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefminox.
Cefmenoxime The risk or severity of nephrotoxicity can be increased when Cefmenoxime is combined with Cefminox.
Cefmetazole The risk or severity of nephrotoxicity can be increased when Cefmetazole is combined with Cefminox.
Indomethacin The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Cefminox.
Triamterene The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Cefminox.
Cefpiramide The risk or severity of nephrotoxicity can be increased when Cefpiramide is combined with Cefminox.
Loracarbef The risk or severity of nephrotoxicity can be increased when Loracarbef is combined with Cefminox.
Cefalotin The risk or severity of nephrotoxicity can be increased when Cefalotin is combined with Cefminox.
Nabumetone The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Cefminox.
Ketorolac The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Cefminox.
Tenoxicam The risk or severity of nephrotoxicity can be increased when Tenoxicam is combined with Cefminox.
Celecoxib The risk or severity of nephrotoxicity can be increased when Celecoxib is combined with Cefminox.
Cefotaxime The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Cefminox.
Tolmetin The risk or severity of nephrotoxicity can be increased when Tolmetin is combined with Cefminox.
Rofecoxib The risk or severity of nephrotoxicity can be increased when Rofecoxib is combined with Cefminox.
Fenoprofen The risk or severity of nephrotoxicity can be increased when Fenoprofen is combined with Cefminox.
Valdecoxib The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Cefminox.
Diclofenac The risk or severity of nephrotoxicity can be increased when Diclofenac is combined with Cefminox.
Sulindac The risk or severity of nephrotoxicity can be increased when Sulindac is combined with Cefminox.
Bacitracin The risk or severity of nephrotoxicity can be increased when Bacitracin is combined with Cefminox.
Amphotericin B The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Cefminox.
Cephaloglycin The risk or severity of nephrotoxicity can be increased when Cephaloglycin is combined with Cefminox.
Adefovir dipivoxil The risk or severity of nephrotoxicity can be increased when Adefovir dipivoxil is combined with Cefminox.
Pentamidine The risk or severity of nephrotoxicity can be increased when Pentamidine is combined with Cefminox.
Mefenamic acid The risk or severity of nephrotoxicity can be increased when Mefenamic acid is combined with Cefminox.
Naproxen The risk or severity of nephrotoxicity can be increased when Naproxen is combined with Cefminox.
Sulfasalazine The risk or severity of nephrotoxicity can be increased when Sulfasalazine is combined with Cefminox.
Phenylbutazone The risk or severity of nephrotoxicity can be increased when Phenylbutazone is combined with Cefminox.
Meloxicam The risk or severity of methemoglobinemia can be increased when Cefminox is combined with Meloxicam.
Carprofen The risk or severity of nephrotoxicity can be increased when Carprofen is combined with Cefminox.
Tacrolimus The risk or severity of nephrotoxicity can be increased when Tacrolimus is combined with Cefminox.
Etacrynic acid The risk or severity of nephrotoxicity can be increased when Etacrynic acid is combined with Cefminox.
Ceforanide The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Cefminox.
Salicylic acid The risk or severity of nephrotoxicity can be increased when Salicylic acid is combined with Cefminox.
Acetylsalicylic acid The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Cefminox.
Hydrochlorothiazide The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Cefminox.
Balsalazide The risk or severity of nephrotoxicity can be increased when Balsalazide is combined with Cefminox.
Cefditoren The risk or severity of nephrotoxicity can be increased when Cefditoren is combined with Cefminox.
Atazanavir The risk or severity of nephrotoxicity can be increased when Atazanavir is combined with Cefminox.
Colistimethate The risk or severity of nephrotoxicity can be increased when Colistimethate is combined with Cefminox.
Cefuroxime The risk or severity of nephrotoxicity can be increased when Cefuroxime is combined with Cefminox.
Cefapirin The risk or severity of nephrotoxicity can be increased when Cefapirin is combined with Cefminox.
Cefprozil The risk or severity of nephrotoxicity can be increased when Cefprozil is combined with Cefminox.
Olsalazine The risk or severity of nephrotoxicity can be increased when Cefminox is combined with Olsalazine.
Lumiracoxib The risk or severity of nephrotoxicity can be increased when Lumiracoxib is combined with Cefminox.
Cefamandole The risk or severity of nephrotoxicity can be increased when Cefamandole is combined with Cefminox.
Cefazolin The risk or severity of nephrotoxicity can be increased when Cefazolin is combined with Cefminox.
Cefonicid The risk or severity of nephrotoxicity can be increased when Cefonicid is combined with Cefminox.
Cefoperazone The risk or severity of nephrotoxicity can be increased when Cefoperazone is combined with Cefminox.
Cefoxitin The risk or severity of nephrotoxicity can be increased when Cefoxitin is combined with Cefminox.
Ceftizoxime The risk or severity of nephrotoxicity can be increased when Ceftizoxime is combined with Cefminox.
Magnesium salicylate The risk or severity of nephrotoxicity can be increased when Magnesium salicylate is combined with Cefminox.
Salsalate The risk or severity of nephrotoxicity can be increased when Salsalate is combined with Cefminox.
Choline magnesium trisalicylate The risk or severity of nephrotoxicity can be increased when Choline magnesium trisalicylate is combined with Cefminox.
Cefepime The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Cefminox.
Cefacetrile The risk or severity of nephrotoxicity can be increased when Cefacetrile is combined with Cefminox.
Cefpodoxime The risk or severity of nephrotoxicity can be increased when Cefpodoxime is combined with Cefminox.
Antrafenine The risk or severity of nephrotoxicity can be increased when Antrafenine is combined with Cefminox.
Aminophenazone The risk or severity of nephrotoxicity can be increased when Aminophenazone is combined with Cefminox.
Antipyrine The risk or severity of nephrotoxicity can be increased when Antipyrine is combined with Cefminox.
Tiaprofenic acid The risk or severity of nephrotoxicity can be increased when Tiaprofenic acid is combined with Cefminox.
Lopinavir The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Cefminox.
Etoricoxib The risk or severity of nephrotoxicity can be increased when Etoricoxib is combined with Cefminox.
Hydrolyzed Cephalothin The risk or severity of nephrotoxicity can be increased when Hydrolyzed Cephalothin is combined with Cefminox.
Cephalothin Group The risk or severity of nephrotoxicity can be increased when Cephalothin Group is combined with Cefminox.
Oxyphenbutazone The risk or severity of nephrotoxicity can be increased when Oxyphenbutazone is combined with Cefminox.
Latamoxef The risk or severity of nephrotoxicity can be increased when Latamoxef is combined with Cefminox.
Nimesulide The risk or severity of nephrotoxicity can be increased when Nimesulide is combined with Cefminox.
Benoxaprofen The risk or severity of nephrotoxicity can be increased when Benoxaprofen is combined with Cefminox.
Metamizole The risk or severity of nephrotoxicity can be increased when Metamizole is combined with Cefminox.
Zomepirac The risk or severity of nephrotoxicity can be increased when Zomepirac is combined with Cefminox.
Ceftobiprole The risk or severity of nephrotoxicity can be increased when Ceftobiprole is combined with Cefminox.
Cimicoxib The risk or severity of nephrotoxicity can be increased when Cimicoxib is combined with Cefminox.
Ceftaroline fosamil The risk or severity of nephrotoxicity can be increased when Ceftaroline fosamil is combined with Cefminox.
Lornoxicam The risk or severity of nephrotoxicity can be increased when Lornoxicam is combined with Cefminox.
Zaltoprofen The risk or severity of nephrotoxicity can be increased when Zaltoprofen is combined with Cefminox.
Azapropazone The risk or severity of nephrotoxicity can be increased when Azapropazone is combined with Cefminox.
Parecoxib The risk or severity of nephrotoxicity can be increased when Parecoxib is combined with Cefminox.
Salicylamide The risk or severity of nephrotoxicity can be increased when Salicylamide is combined with Cefminox.
Kebuzone The risk or severity of nephrotoxicity can be increased when Kebuzone is combined with Cefminox.
Isoxicam The risk or severity of nephrotoxicity can be increased when Isoxicam is combined with Cefminox.
Indoprofen The risk or severity of nephrotoxicity can be increased when Indoprofen is combined with Cefminox.
Ibuproxam The risk or severity of nephrotoxicity can be increased when Ibuproxam is combined with Cefminox.
Floctafenine The risk or severity of nephrotoxicity can be increased when Floctafenine is combined with Cefminox.
Fenbufen The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Cefminox.
Etofenamate The risk or severity of nephrotoxicity can be increased when Etofenamate is combined with Cefminox.
Epirizole The risk or severity of nephrotoxicity can be increased when Epirizole is combined with Cefminox.
Cefaloridine The risk or severity of nephrotoxicity can be increased when Cefaloridine is combined with Cefminox.
Dexibuprofen The risk or severity of nephrotoxicity can be increased when Cefminox is combined with Dexibuprofen.
Droxicam The risk or severity of nephrotoxicity can be increased when Cefminox is combined with Droxicam.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 1
International Brands
  • Meicelin

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul